Black Rock Inc. Opti Nose, Inc. Transaction History

Black Rock Inc.

$4.23 Trillion
Q1 2024

A detailed history of Black Rock Inc. transactions in Opti Nose, Inc. stock. As of the latest transaction made, Black Rock Inc. holds 4,283,316 shares of OPTN stock, worth $4.41 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

4,283,316

Previous 4,404,251 2.75%

Holding current value

$4.41 Million

Previous $5.68 Million 10.07%

% of portfolio

0.0%

Previous 0.0%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 10, 2024	SELL	$1.17 - $1.94 $141,493 - $234,613	-120,935 Reduced 2.75%	4,283,316 $6.25 Million
Q4 2023 Feb 13, 2024	BUY	$1.02 - $1.47 $230,908 - $332,780	226,381 Added 5.42%	4,404,251 $5.68 Million
Q3 2023 Nov 13, 2023	BUY	$0.93 - $1.38 $255,392 - $378,970	274,616 Added 7.04%	4,177,870 $5.14 Million
Q2 2023 Aug 11, 2023	BUY	$1.11 - $2.05 $3.6 Million - $6.65 Million	3,246,231 Added 494.08%	3,903,254 $4.8 Million
Q1 2023 May 12, 2023	BUY	$1.63 - $2.02 $47,925 - $59,392	29,402 Added 4.68%	657,023 $1.27 Million

Q4 2022 Feb 13, 2023	SELL	$1.68 - $3.7 $54,295 - $119,580	-32,319 Reduced 4.9%	627,621 $1.16 Million
Q3 2022 Nov 14, 2022	SELL	$3.43 - $4.01 $279,016 - $326,197	-81,346 Reduced 10.97%	659,940 $2.42 Million
Q2 2022 Aug 12, 2022	SELL	$1.76 - $3.82 $54,744 - $118,821	-31,105 Reduced 4.03%	741,286 $2.71 Million
Q1 2022 May 12, 2022	BUY	$1.77 - $2.93 $39,224 - $64,931	22,161 Added 2.95%	772,391 $1.91 Million
Q4 2021 Feb 10, 2022	BUY	$1.55 - $3.1 $31,147 - $62,294	20,095 Added 2.75%	750,230 $1.22 Million
Q3 2021 Nov 09, 2021	BUY	$2.35 - $3.16 $276,877 - $372,311	117,820 Added 19.24%	730,135 $2.19 Million
Q2 2021 Aug 11, 2021	BUY	$2.91 - $3.83 $1.78 Million - $2.35 Million	612,315 New	612,315 $1.9 Million

Others Institutions Holding OPTN

# of Institutions

Shares Held

59.6M

Call Options Held

Put Options Held

View Full List

About OptiNose, Inc.

Ticker OPTN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 83,277,504
Market Cap $85.8M
Description
OptiNose, Inc., a specialty pharmaceutical company, focuses on the development and commercialization of products for patients treated by ear, nose, throat, and allergy specialists in the United States. The company offers XHANCE, a therapeutic product utilizing its proprietary exhalation delivery system (EDS) that delivers a topically-acting cort...

More about OPTN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Black Rock Inc., based on Form 13F filings with the SEC.

News

Stay updated on Black Rock Inc. with notifications on news.

Account